Stuver R, Drill E, Michaud L, Casulo C, Advani RH, Budde EL, Barr PM, Lee Batlevi C, Caron PC, Constine LS, Drullinsky P, Dandapani SV, Friedberg JW, Grieve C, Hamlin PA, Hoppe R, Horwitz SM, Khan N, Joseph A, Matasar MJ, Noy A, Palomba ML, Schöder H, Sraus DJ, Vemuri S, Yahalom J, Yang JC, Zelenetz AD, Moskowitz CH, Kumar A, Moskowitz AJ. Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma. Haematologica; https://doi.org/10.3324/haematol.2026.301587 [Early view].